THE CLINICAL-PHARMACOLOGY OF METHOTREXATE

被引：114

作者：

SCHORNAGEL, JH ^{[1
]}

MCVIE, JG ^{[1
]}

机构：

[1] NETHERLANDS CANC INST,CLIN RES UNIT,1066 CX AMSTERDAM,NETHERLANDS

来源：

CANCER TREATMENT REVIEWS | 1983年 / 10卷 / 01期

关键词：

D O I：

10.1016/S0305-7372(83)80032-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：53 / 75

页数：23

共 192 条

[31]

BOWEN D, 1980, CANCER CHEMOTH PHARM, V4, P111

[32] LIMITED EFFECTIVENESS OF INVITRO HIGH-DOSE METHOTREXATE AND LEUCOVORIN TO OVERCOME RESISTANCE IN L1210 LEUKEMIA-CELLS WITH ELEVATIONS OF DIHYDROFOLATE-REDUCTASE [J].

BRUCKNER, H ;

RUBINOFF, M ;

WAXMAN, S .

EUROPEAN JOURNAL OF CANCER, 1980, 16 (08) :1057-1063

[33]

BRUCKNER HW, 1975, CANCER RES, V34, P801

[34]

BUESAPEREZ JM, 1980, CANCER RES, V40, P139

[35]

BURCHENAL JH, 1977, CANCER TREAT REP, V61, P657

[36]

CALVERT AH, 1977, CANCER TREAT REP, V61, P1647

[37]

CAPIZZI RL, 1974, BIOCHEM PHARMACOL, V23, P151

[38]

CAPIZZI RL, 1970, CANCER RES, V30, P1782

[39] THRESHOLD METHOTREXATE CONCENTRATION FOR IN-VIVO INHIBITION OF DNA-SYNTHESIS IN NORMAL AND TUMOROUS TARGET TISSUES [J].

CHABNER, BA ;

YOUNG, RC .

JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (08) :1804-1811

[40] ENZYMATIC CLEAVAGE OF METHOTREXATE PROVIDES A METHOD FOR PREVENTION OF DRUG TOXICITY [J].

CHABNER, BA ;

BERTINO, JR ;

JOHNS, DG .

NATURE, 1972, 239 (5372) :395-&

← 1 2 3 4 5 6 7 8 9 10 →